Article Text

Download PDFPDF
The retinal “lozenge” or “dull macular reflex” in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure
  1. D Colville,
  2. Y Y Wang,
  3. R Tan,
  4. J Savige
  1. The University of Melbourne Department of Medicine, Northern Health, Epping, Australia
  1. Professor J Savige, The University of Melbourne, Department of Medicine (Northern Health), The Northern Hospital, Epping VIC 3076, Australia; jasavige{at}


Background and aims: Alport syndrome is an inherited disease with renal failure, and often a hearing loss, lenticonus and dot-and-fleck retinopathy. A retinal “lozenge” or “dull macular reflex” has been described in some patients. This study determined the prevalence and significance of this sign.

Methods: Twenty-three patients from 14 families with X linked Alport syndrome and seven from four families with autosomal recessive disease underwent slit-lamp biomicroscopy for lenticonus, direct and indirect ophthalmoscopy, and photography for the retinopathy.

Results: The lozenge was present in five males (38%) but no females with X linked Alport syndrome, as well as one individual with recessive disease (1/7, 14%). It resulted from the sharp demarcation between the normal fovea and a perifoveal annnulus of confluent dots and flecks that were obvious with magnification of retinal photographs. The lozenge was first noted in adolescence and was always associated with early-onset renal failure, hearing loss and lenticonus.

Conclusion: Clinicians must be aware that the “lozenge” or “dull macular reflex” described in Alport syndrome is not a normal variant but reflects a severe, almost confluent perimacular dot and fleck retinopathy. This sign is useful diagnostically and also prognostically, since it is associated with early-onset renal failure.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Funding: This work was supported by the National Health and Medical Research Council of Australia, Kidney Health Australia and the Northern Health Education, Equipment and Research Fund.

  • Competing interests: None.

  • Ethics approval: Ethics approval was provided by the Human Research Ethics Committee of Northern Health.

  • Patient consent: Obtained.